Advanced BioHealing's Kevin Rakin to Present at 21st Annual Piper Jaffray Health Care Conference.

WESTPORT, Conn. -- Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that Chairman and Chief Executive Officer Kevin Rakin will present at the 21st Annual Piper Jaffray Health Care Conference. The conference will be held December 1-2, 2009, at the New York Palace Hotel in New York City, NY.

Mr. Rakin's presentation is scheduled for Tuesday, December 1, 2009, at 3:10 p.m. He will review ABH's growth over the last three years, the current state of the business, and offer a detailed discussion of the Company's strategic plans for growth over the next three to five years. Since launching commercial operations in 2007, ABH has experienced double-digit revenue growth and is projecting more than $80 million in annual revenue for 2009 and over 250 employees by year-end 2009.

"We are pleased to have been invited to present at this year's Piper Jaffray Health Care Conference," said Rakin. "We've successfully commercialized a regenerative medicine product and have set our sights on new growth initiatives to extend the positive impact that regenerative medicine can have on healthcare. I look forward to sharing the ABH commercialization success story and future plans with conference attendees."

Company and investor participation in the Piper Jaffray Health Care Conference is by invitation only.

About Advanced BioHealing, Inc.

Advanced BioHealing develops and commercializes living cell technologies that repair damaged human tissue and enable the body to heal itself. A privately held company with more than 200 employees, Advanced BioHealing maintains corporate offices in Westport, CT and a 70,000 sq. ft. manufacturing facility in La Jolla, CA. To meet Advanced BioHealing's executives and learn more about the Company, please visit the Company's web site at www.ABH.com.